Development and validation of a nomogram model based on pretreatment ultrasound and contrast-enhanced ultrasound to predict the efficacy of neoadjuvant chemotherapy in patients with borderline resectable or locally advanced pancreatic cancer
Abstract Objectives To develop a nomogram using pretreatment ultrasound (US) and contrast-enhanced ultrasound (CEUS) to predict the clinical response of neoadjuvant chemotherapy (NAC) in patients with borderline resectable pancreatic cancer (BRPC) or locally advanced pancreatic cancer (LAPC). Method...
Main Authors: | Xiaoyi Yan, Xianshui Fu, Yang Gui, Xueqi Chen, Yuejuan Cheng, Menghua Dai, Weibin Wang, Mengsu Xiao, Li Tan, Jing Zhang, Yuming Shao, Huanyu Wang, Xiaoyan Chang, Ke Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Cancer Imaging |
Online Access: | https://doi.org/10.1186/s40644-024-00662-2 |
Similar Items
-
Predicting the Efficacy of Neoadjuvant Chemotherapy for Pancreatic Cancer Using Deep Learning of Contrast-Enhanced Ultrasound Videos
by: Yuming Shao, et al.
Published: (2023-06-01) -
Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
by: Marco Massani, et al.
Published: (2023-01-01) -
An ultrasound-based nomogram model in the assessment of pathological complete response of neoadjuvant chemotherapy in breast cancer
by: Jinhui Liu, et al.
Published: (2024-03-01) -
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
by: Jordan M. Cloyd, et al.
Published: (2020-04-01) -
Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?
by: Violette Fossaert, et al.
Published: (2022-10-01)